Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex Differences in Clinical Outcomes and Loss of Life Expectancy After Aortic Valve Surgery for Infective Endocarditis: A SWEDEHEART Study.

Journal of the American Heart Association·2026
Same author

Ferroptosis promotes aortic stenosis through 5-lipoxygenase.

European heart journal·2026
Same author

Rare regulatory mutations disrupt mesenchymal molecular programs driving endocardial cushion formation in bicuspid aortic valve.

Nature communications·2026
Same author

Oral paraneoplastic manifestations and findings associated with extra-oral surgically treated malignancies: a prospective cross-sectional study of 300 cases.

World journal of surgical oncology·2026
Same author

The progression of proliferative verrucous leukoplakia can be detected through elevated levels of salivary matrix metalloproteinases.

BMC oral health·2026
Same author

Proliferative verrucous leukoplakia management requires x-ray surveillance. A retrospective study of 78 cases.

Clinical oral investigations·2026
Same journal

Impact of Patient-Specific Material Properties on Aneurysm Wall Stress: Finite Element Study.

The Journal of heart valve disease·2021
Same journal

Range of Pulmonary Autograft Responses to Systemic Pressure Immediately After Ross Procedure.

The Journal of heart valve disease·2021
Same journal

Evolution of Bilateral Mammary Arterial Grafting Program in Veterans Affairs Medical Center.

The Journal of heart valve disease·2021
Same journal

Double Valve Failure Due to Perceval Sutureless Aortic Valve Migration.

The Journal of heart valve disease·2018
Same journal

Use of AngioVac for Removal of Tricuspid Valve Vegetation.

The Journal of heart valve disease·2018
Same journal

Management of Late Paravalvular Leak after Transcatheter Valve Placement in Calcified Mitral Annulus.

The Journal of heart valve disease·2018
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

Endothelin-1 and brain natriuretic peptide plasma levels decrease after aortic surgery.

Giuseppe M Raffa1, Veronica Jackson, Jan Liska

  • 1Department of Cardiac Surgery, IRCCS Istituto Clinico Humanitas, Rozzano (MI), Italy. giuseppe.raffa78@gmail.com

The Journal of Heart Valve Disease
|January 11, 2011
PubMed
Summary
This summary is machine-generated.

Surgery for aortic disease significantly reduced levels of endothelin-1 (ET-1) and B-type natriuretic peptide (BNP). These peptide reductions reflect improved cardiac function and remodeling post-operation.

More Related Videos

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves
07:12

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves

Published on: August 23, 2011

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

Related Experiment Videos

Last Updated: Jun 5, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves
07:12

Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves

Published on: August 23, 2011

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

Area of Science:

  • Cardiovascular Medicine
  • Cardiac Surgery
  • Biomarkers

Background:

  • Endothelin-1 (ET-1) and B-type natriuretic peptide (BNP) are implicated in cardiovascular diseases.
  • Aortic diseases encompass conditions affecting the aorta, including valve stenosis, regurgitation, and aneurysms.

Purpose of the Study:

  • To monitor circulating plasma levels of ET-1 and BNP in patients with aortic disease.
  • To identify changes in ET-1 and BNP levels following surgical intervention for aortic disease.

Main Methods:

  • 81 patients with various aortic diseases underwent surgical treatment.
  • Plasma levels of ET-1 and BNP were measured preoperatively and at 12 months post-surgery.
  • Patient conditions included aortic valve stenosis, regurgitation, ascending aortic aneurysm, and combined pathologies.

Main Results:

  • Postoperative plasma levels of ET-1 and BNP significantly decreased (p < 0.001).
  • Cardiac function improved, and ventricular dimensions decreased after surgery.
  • Preoperative peptide levels were similar across diagnoses, with ET-1 higher in trileaflet compared to bicuspid aortic valves (p = 0.04).

Conclusions:

  • Surgical treatment for aortic valve disease leads to reduced circulating ET-1 and BNP levels.
  • The observed decrease in peptides is likely a response to cardiac remodeling and improved functional status.
  • The reduction was independent of ascending aortic aneurysm presence.